CN101568552A - 胶原肽组合物以及含有其的饮食品 - Google Patents
胶原肽组合物以及含有其的饮食品 Download PDFInfo
- Publication number
- CN101568552A CN101568552A CNA2007800480596A CN200780048059A CN101568552A CN 101568552 A CN101568552 A CN 101568552A CN A2007800480596 A CNA2007800480596 A CN A2007800480596A CN 200780048059 A CN200780048059 A CN 200780048059A CN 101568552 A CN101568552 A CN 101568552A
- Authority
- CN
- China
- Prior art keywords
- collagen
- collagen peptide
- peptide
- blood
- peptide composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 200
- 108010035532 Collagen Proteins 0.000 title claims abstract description 198
- 102000008186 Collagen Human genes 0.000 title claims abstract description 197
- 229920001436 collagen Polymers 0.000 title claims abstract description 195
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- 235000013305 food Nutrition 0.000 title abstract description 18
- 235000013361 beverage Nutrition 0.000 title abstract description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000004471 Glycine Substances 0.000 claims abstract description 29
- 108010010803 Gelatin Proteins 0.000 claims abstract description 26
- 239000008273 gelatin Substances 0.000 claims abstract description 26
- 229920000159 gelatin Polymers 0.000 claims abstract description 26
- 235000019322 gelatine Nutrition 0.000 claims abstract description 26
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 26
- 108091005804 Peptidases Proteins 0.000 claims abstract description 11
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 23
- 235000005911 diet Nutrition 0.000 claims description 22
- 230000037213 diet Effects 0.000 claims description 22
- 241000251468 Actinopterygii Species 0.000 claims description 17
- 102000035195 Peptidases Human genes 0.000 claims description 10
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 claims description 4
- 108010022999 Serine Proteases Proteins 0.000 claims description 4
- 102000012479 Serine Proteases Human genes 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 abstract description 56
- 239000008280 blood Substances 0.000 abstract description 56
- 108010038807 Oligopeptides Proteins 0.000 abstract description 9
- 102000015636 Oligopeptides Human genes 0.000 abstract description 9
- 239000004365 Protease Substances 0.000 abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- 125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 239000000047 product Substances 0.000 description 25
- 150000001413 amino acids Chemical class 0.000 description 23
- 230000009471 action Effects 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 235000019688 fish Nutrition 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 210000002381 plasma Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 108010091748 peptide A Proteins 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000029816 Collagenase Human genes 0.000 description 7
- 108060005980 Collagenase Proteins 0.000 description 7
- 229960002424 collagenase Drugs 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- PCFGFYKGPMQDBX-FEKONODYSA-N 78355-50-7 Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 PCFGFYKGPMQDBX-FEKONODYSA-N 0.000 description 5
- 101800005149 Peptide B Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 108010069653 peptide E (adrenal medulla) Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 108010011485 Aspartame Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 238000010241 blood sampling Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 108010005636 polypeptide C Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 241000252230 Ctenopharyngodon idella Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108090001126 Furin Proteins 0.000 description 2
- 102000004961 Furin Human genes 0.000 description 2
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 101710172072 Kexin Proteins 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 235000011116 calcium hydroxide Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 108090000200 cucumisin Proteins 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 235000015094 jam Nutrition 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- -1 oleomargarine Substances 0.000 description 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 238000000734 protein sequencing Methods 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QEDRTIXTEAXNMY-XVMARJQXSA-N 2-[[(2s,4r)-1-[(2s)-2-aminopropanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetic acid Chemical compound C[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(O)=O QEDRTIXTEAXNMY-XVMARJQXSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000155247 Ixos Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- WJSNJMXOBDSZDL-WOPDTQHZSA-N L-phenylalanyl-L-hydroxyproline Chemical compound C([C@H](N)C(=O)N1[C@@H](C[C@@H](O)C1)C(O)=O)C1=CC=CC=C1 WJSNJMXOBDSZDL-WOPDTQHZSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 241001147156 Lates niloticus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100443291 Mus musculus Dnajc27 gene Proteins 0.000 description 1
- 241001275898 Mylopharyngodon piceus Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- ONPXCLZMBSJLSP-CSMHCCOUSA-N Pro-Hyp Chemical compound C1[C@H](O)C[C@@H](C(O)=O)N1C(=O)[C@H]1NCCC1 ONPXCLZMBSJLSP-CSMHCCOUSA-N 0.000 description 1
- 241000287531 Psittacidae Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241001406921 Squamosa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001494106 Stenotomus chrysops Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 108090000350 actinidain Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009921 drying by method Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000015168 fish fingers Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 108010031354 thermitase Proteins 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/06—Gelatine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
Abstract
Description
胶原肽组合物 | 肽型羟脯氨酸量(hr·nmol/ml,平均值±S.E.) |
本发明的胶原肽 | 401.1±29.2 |
胶原肽A | 220.6±18.7* |
胶原肽B | 245.4±18.5* |
胶原肽C | 190.0±11.8* |
胶原肽D | 277.2±12.6* |
胶原肽组合物 | 1小时后(nmol/ml) | 2小时后(nmol/ml) |
本发明的胶原肽 | 94.8±9.3 | 125.5±12.9 |
胶原肽A | 53.8±5.7*1 | 63.0±5.6*1 |
胶原肽B | 65.3±6.5*2 | 76.2±6.7*1 |
胶原肽C | 55.3±11.8*1 | 67.1±10.0*1 |
胶原肽D | 57.3±2.5*1 | 83.3±6.6*1 |
肽体 | 本发明的胶原肽 | 胶原肽A | 胶原肽D |
Ala-Hyp-Gly | 30.9 | 0 | 0 |
Ser-Hyp-Gly | 23.7 | 0 | 0 |
Pro-Hyp | 69.5 | 22.6 | 54.4 |
Pro-Hyp-Gly | 4.4 | 1.6 | 0 |
Ile-Hyp | 3 | 3.8 | 0.6 |
Leu-Hyp | 10.5 | 14.5 | 1.7 |
Phe-Hyp | 3.6 | 3.8 | 0.6 |
胶原肽组合物 | N末端氨基酸中甘氨酸所占比例(摩尔%) |
本发明的胶原肽组合物 | 59.4 |
胶原肽A | 69.0 |
胶原肽B | 21.6 |
胶原肽C | 25.3 |
胶原肽D | 65.4 |
本发明的胶原肽组合物(试样名) | 酶名和酶量(相对于每1kg明胶) | 反应pH、反应温度和反应时间 | 失活条件 | 纯化条件 |
02A | 枯草杆菌蛋白酶(6.0g) | pH8.0,50℃,6小时 | 90℃以上,10分钟 | 微粉活性炭2.0%添加明胶后纯化过滤 |
02B | 胰凝乳蛋白酶(6.0g) | pH8.0,40℃,6小时 | 同上 | 同上 |
02N | 奇异果蛋白酶(6.0g) | pH7.5,40℃,6小时 | 同上 | 同上 |
02AF | 枯草杆菌蛋白酶(5.5g)和菠萝蛋白酶(3.0g)的混合酶 | pH8.0,40℃,6小时 | 同上 | 同上 |
02BF | 胰凝乳蛋白酶(5.5g)和菠萝蛋白酶(3.0g)的混合酶 | pH8.0,40℃,6小时 | 同上 | 同上 |
本发明的胶原肽组合物(试样名) | N末端氨基酸中甘氨酸量所占比例(摩尔%) | 分子量500以下(%) | 分子量500以上、3000以下(%) | 分子量3000以上(%) |
02A | 56.7 | 4.4 | 88.0 | 7.7 |
02B | 63.6 | 3.8 | 87.6 | 8.6 |
02N | 36.4 | 5.0 | 85.7 | 9.3 |
02AF | 58.9 | 4.0 | 87.1 | 8.9 |
02BF | 64.9 | 4.5 | 87.8 | 7.7 |
胶原肽组合物 | 肽型羟脯氨酸量(hr·nmol/ml:平均值±S.E.) |
胶原肽D(实施例2) | 155.0±12.5 |
02A | 247.4±7.9** |
02B | 281.9±20.6** |
02N | 264.5±44.3 |
02AF | 269.7±26.0** |
02BF | 257.2±47.5 |
胶原肽组合物 | 1小时后 | 2小时后 |
胶原肽D(实施例2) | 29.82±5.13 | 27.84±2.91 |
02A | 40.77±4.90 | 54.75±3.70** |
02B | 42.00±5.72 | 66.04±9.70* |
02N | 44.28±5.84 | 58.24±11.53 |
02AF | 42.16±4.14 | 66.06±10.36* |
02BF | 41.33±10.48 | 61.55±13.41 |
胶原肽组合物 | 肽型羟脯氨酸量(hr·nmol/ml:平均值±S.E.) |
胶原肽E | 225.8±21.2 |
02B | 241.0±19.4 |
02N | 255.1±19.9** |
胶原肽组合物 | 1小时后 | 2小时后 |
胶原肽E | 63.5±28.4 | 67.7±30.1 |
02B | 76.6±26.2 | 79.4±30.6 |
02N | 82.5±25.1** | 80.8±24.6* |
Claims (4)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP309032/2006 | 2006-11-15 | ||
JP2006309032 | 2006-11-15 | ||
PCT/JP2007/072196 WO2008059927A1 (fr) | 2006-11-15 | 2007-11-15 | Composition de peptide de collagène et aliment ou boisson la contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101568552A true CN101568552A (zh) | 2009-10-28 |
CN101568552B CN101568552B (zh) | 2014-03-26 |
Family
ID=39401731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200780048059.6A Active CN101568552B (zh) | 2006-11-15 | 2007-11-15 | 胶原肽组合物以及含有其的饮食品 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20100068342A1 (zh) |
EP (1) | EP2088157A4 (zh) |
JP (2) | JP5689222B2 (zh) |
KR (1) | KR101095698B1 (zh) |
CN (1) | CN101568552B (zh) |
CA (1) | CA2669524C (zh) |
HK (1) | HK1136586A1 (zh) |
SG (1) | SG176466A1 (zh) |
WO (1) | WO2008059927A1 (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102090684A (zh) * | 2010-09-06 | 2011-06-15 | 山东好当家海洋发展股份有限公司 | 一种海产胶原蛋白肽饮料及其制备方法 |
CN102125148A (zh) * | 2011-03-02 | 2011-07-20 | 烟台龙普生物科技有限责任公司 | 一种胶原蛋白肽巧克力制作方法 |
CN103841840A (zh) * | 2011-10-07 | 2014-06-04 | 富士胶片株式会社 | 饮料组合物 |
CN104768566A (zh) * | 2012-11-06 | 2015-07-08 | 格利达股份公司 | 胶原水解物及其用途 |
CN108601813A (zh) * | 2016-02-03 | 2018-09-28 | 费森尤斯卡比德国有限公司 | 包含胶原蛋白的高热量高蛋白质营养配方物 |
CN109988235A (zh) * | 2019-04-09 | 2019-07-09 | 浙江荣舟海洋产业股份有限公司 | 一种金枪鱼蛋白肽的制备方法 |
CN111295208A (zh) * | 2017-10-20 | 2020-06-16 | 株式会社大塚制药工场 | 防粘连材料 |
CN111345387A (zh) * | 2018-12-21 | 2020-06-30 | 大连鑫玉龙海洋生物种业科技股份有限公司 | 一种海参肽软糖配方及其制备方法 |
CN113122604A (zh) * | 2021-05-25 | 2021-07-16 | 山东大学 | 一种海肠胶及其制备方法和应用 |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4709730B2 (ja) * | 2006-11-15 | 2011-06-22 | 新田ゼラチン株式会社 | チュアブルタブレット |
US20090258833A1 (en) * | 2008-04-10 | 2009-10-15 | Edward Walker | Fortified liquid protein compositions and methods of making same |
JP2009280508A (ja) * | 2008-05-20 | 2009-12-03 | Hikari Ishii | 血管老化抑制剤および老化防止抑制製剤 |
TWI360421B (en) * | 2008-05-23 | 2012-03-21 | Tung Ching Wang | Method for manufacturing a composition of peptide, |
JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
JP4767328B2 (ja) * | 2009-01-22 | 2011-09-07 | 柳瀬ワイチ株式会社 | 母乳搾乳器 |
WO2010103837A1 (ja) * | 2009-03-11 | 2010-09-16 | ゼライス株式会社 | アテローム性動脈硬化症の進行抑制薬・予防薬・血中コレステロール低下薬・機能性食品・特定保健用食品 |
EP2426138B1 (en) | 2009-04-28 | 2015-07-01 | Meiji Co., Ltd. | Collagen peptide composition having good blood transfer properties, and food and drink containing same |
JP5726424B2 (ja) * | 2010-02-26 | 2015-06-03 | 焼津水産化学工業株式会社 | コラーゲンペプチド粉体組成物及びその製造方法 |
TWI449500B (zh) * | 2010-02-26 | 2014-08-21 | Melodian Co Ltd | 營養補充食品及其製造方法 |
JP5429033B2 (ja) * | 2010-05-07 | 2014-02-26 | ユーハ味覚糖株式会社 | グミキャンディ様構造物及びその製造方法 |
DE102010060564A1 (de) | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
JP5901125B2 (ja) * | 2011-03-18 | 2016-04-06 | 焼津水産化学工業株式会社 | コラーゲンペプチド含有粉体組成物及びその製造方法 |
CA2854856C (en) | 2011-11-29 | 2020-03-10 | Gelita Ag | Collagen hydrolysate and use thereof |
US20130156926A1 (en) * | 2011-12-14 | 2013-06-20 | Alice Chang | Milk collagen jelly system, collagen jelly system, and with ingredients |
JP6165449B2 (ja) * | 2012-02-01 | 2017-07-19 | 三栄源エフ・エフ・アイ株式会社 | 発酵乳食品 |
KR101413086B1 (ko) * | 2012-08-13 | 2014-06-27 | 대한민국 | 젤라틴의 가수분해물을 포함하는 발효유 조성물 |
JP6023514B2 (ja) * | 2012-08-30 | 2016-11-09 | キユーピー株式会社 | 組成物の製造方法 |
ES2791448T3 (es) | 2013-01-23 | 2020-11-04 | Bottled Science Ltd | Composición de bebida para mejorar la piel |
JP6173054B2 (ja) * | 2013-06-07 | 2017-08-02 | 株式会社東洋新薬 | コラーゲンペプチドの調製方法および良吸収性コラーゲンペプチド |
JP2014088409A (ja) * | 2013-12-20 | 2014-05-15 | Jnc Corp | タンパク質の安定化剤 |
EP3147988B1 (en) * | 2014-05-19 | 2018-10-31 | Hitachi, Ltd. | Negative electrode material, negative electrode for lithium ion secondary battery, lithium ion secondary battery, and process for producing same |
US20200077682A1 (en) * | 2015-01-16 | 2020-03-12 | Welldrinks Ltd | Beverage with collagen and additional additives |
US10253090B2 (en) | 2016-03-22 | 2019-04-09 | Avicenna Nutraceutical, Llc | Hydrolyzed collagen compositions and methods of making thereof |
FR3058142B1 (fr) | 2016-10-28 | 2023-11-24 | Gelatines Weishardt | Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament |
WO2018091566A1 (en) * | 2016-11-16 | 2018-05-24 | Fresenius Kabi Deutschland Gmbh | Nutritional composition for use in therapy of patients with copd, neurological diseases or disorders and/or wounds |
KR101874571B1 (ko) * | 2016-12-07 | 2018-07-04 | 주식회사 마린테크노 | 마린 콜라겐을 이용한 빵 및 과자의 제조방법 |
EP3469916B1 (en) * | 2017-10-16 | 2020-04-15 | Derin, Anatoly | Oral delivery system for collagen peptides |
KR102259842B1 (ko) | 2019-07-23 | 2021-06-01 | 충북대학교 산학협력단 | 천연 단백질 분해효소를 이용한 콜라겐 저분자 펩타이드 제조방법 |
CN110664983A (zh) * | 2019-08-26 | 2020-01-10 | 王良军 | 一种活性肽组合配制酒及其制备方法 |
KR102200702B1 (ko) * | 2020-09-07 | 2021-01-08 | 구영훈 | 저분자 콜라겐이 함유된 하드캔디의 제조방법 및 그에 따라 제조된 하드캔디 |
KR102525595B1 (ko) * | 2022-09-15 | 2023-04-27 | (주)모노랩스 | 피쉬 콜라겐 함유 건강 식품 조성물 |
WO2024128031A1 (ja) * | 2022-12-14 | 2024-06-20 | 株式会社シクロケム | コラーゲン・シクロデキストリン混合食品組成物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3782122B2 (ja) | 1994-04-11 | 2006-06-07 | サンスター株式会社 | 経口摂取用新陳代謝促進剤およびそれを配合した食品 |
JP3308433B2 (ja) | 1995-08-31 | 2002-07-29 | 株式会社資生堂 | 皮膚賦活食品 |
JP4609807B2 (ja) | 1996-03-28 | 2011-01-12 | 雪印乳業株式会社 | 骨強化用医薬、飲食品及び飼料 |
US5670369A (en) * | 1996-06-25 | 1997-09-23 | Ranpak Corporation | Method for the production of soluble collagen |
JPH1112192A (ja) | 1997-06-18 | 1999-01-19 | Zenyaku Kogyo Kk | 骨粗鬆症予防・治療剤 |
US6025327A (en) * | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
JP4023648B2 (ja) * | 1999-01-13 | 2007-12-19 | 日本ハム株式会社 | 皮膚代謝促進物及び機能性食品 |
JP3802721B2 (ja) | 1999-11-05 | 2006-07-26 | 株式会社ファンケル | 生体コラーゲン合成促進剤 |
JP4377522B2 (ja) * | 2000-05-09 | 2009-12-02 | 株式会社ヤクルト本社 | 安定な酸性乳飲料、その製造方法およびこれに使用する酸性乳飲料用添加剤 |
JP2003137807A (ja) | 2001-11-01 | 2003-05-14 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤 |
JP2004244369A (ja) * | 2003-02-13 | 2004-09-02 | Jellice Co Ltd | ペプチド組成物、その製造方法およびペプチド添加物質 |
JP4436084B2 (ja) * | 2003-08-04 | 2010-03-24 | 日本メナード化粧品株式会社 | コラーゲン産生促進剤及びコラーゲン架橋形成阻害剤 |
JP2005314265A (ja) * | 2004-04-28 | 2005-11-10 | Nippon Menaade Keshohin Kk | 老化防止剤 |
JP2006151847A (ja) * | 2004-11-26 | 2006-06-15 | Nitta Gelatin Inc | コラーゲンペプチド組成物とその製造方法、化粧料組成物 |
CN1683550B (zh) * | 2005-03-08 | 2010-12-01 | 国家海洋局第一海洋研究所 | 胶原蛋白及其制备工艺 |
JP2006309032A (ja) | 2005-04-28 | 2006-11-09 | Konica Minolta Business Technologies Inc | 画像形成装置および画像形成方法 |
US7495076B2 (en) * | 2005-10-13 | 2009-02-24 | Gu Jennifer L | Mineral collagen chelates and methods of making and using same |
CN1814782A (zh) * | 2005-11-28 | 2006-08-09 | 海南莱顿生物技术有限公司 | 利用酶工程技术从鱼鳞中提取小分子胶原蛋白的方法 |
-
2007
- 2007-11-15 CN CN200780048059.6A patent/CN101568552B/zh active Active
- 2007-11-15 JP JP2008544197A patent/JP5689222B2/ja active Active
- 2007-11-15 WO PCT/JP2007/072196 patent/WO2008059927A1/ja active Application Filing
- 2007-11-15 CA CA2669524A patent/CA2669524C/en active Active
- 2007-11-15 EP EP07831926A patent/EP2088157A4/en not_active Withdrawn
- 2007-11-15 SG SG2011082237A patent/SG176466A1/en unknown
- 2007-11-15 US US12/312,513 patent/US20100068342A1/en not_active Abandoned
- 2007-11-15 KR KR1020097012213A patent/KR101095698B1/ko active IP Right Grant
-
2010
- 2010-03-26 HK HK10103161.5A patent/HK1136586A1/zh unknown
-
2012
- 2012-09-05 JP JP2012194906A patent/JP2013034478A/ja active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102090684A (zh) * | 2010-09-06 | 2011-06-15 | 山东好当家海洋发展股份有限公司 | 一种海产胶原蛋白肽饮料及其制备方法 |
CN102125148A (zh) * | 2011-03-02 | 2011-07-20 | 烟台龙普生物科技有限责任公司 | 一种胶原蛋白肽巧克力制作方法 |
CN103841840A (zh) * | 2011-10-07 | 2014-06-04 | 富士胶片株式会社 | 饮料组合物 |
CN104768566A (zh) * | 2012-11-06 | 2015-07-08 | 格利达股份公司 | 胶原水解物及其用途 |
CN104768566B (zh) * | 2012-11-06 | 2018-06-29 | 格利达股份公司 | 胶原水解物及其用途 |
CN108601813A (zh) * | 2016-02-03 | 2018-09-28 | 费森尤斯卡比德国有限公司 | 包含胶原蛋白的高热量高蛋白质营养配方物 |
CN108601813B (zh) * | 2016-02-03 | 2022-02-25 | 费森尤斯卡比德国有限公司 | 包含胶原蛋白的高热量高蛋白质营养配方物 |
CN111295208A (zh) * | 2017-10-20 | 2020-06-16 | 株式会社大塚制药工场 | 防粘连材料 |
CN111345387A (zh) * | 2018-12-21 | 2020-06-30 | 大连鑫玉龙海洋生物种业科技股份有限公司 | 一种海参肽软糖配方及其制备方法 |
CN109988235A (zh) * | 2019-04-09 | 2019-07-09 | 浙江荣舟海洋产业股份有限公司 | 一种金枪鱼蛋白肽的制备方法 |
CN113122604A (zh) * | 2021-05-25 | 2021-07-16 | 山东大学 | 一种海肠胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2008059927A1 (fr) | 2008-05-22 |
SG176466A1 (en) | 2011-12-29 |
KR20090089411A (ko) | 2009-08-21 |
CA2669524C (en) | 2015-02-17 |
HK1136586A1 (zh) | 2010-07-02 |
EP2088157A1 (en) | 2009-08-12 |
CA2669524A1 (en) | 2008-05-22 |
US20100068342A1 (en) | 2010-03-18 |
CN101568552B (zh) | 2014-03-26 |
JP5689222B2 (ja) | 2015-03-25 |
KR101095698B1 (ko) | 2011-12-20 |
EP2088157A4 (en) | 2009-12-30 |
JP2013034478A (ja) | 2013-02-21 |
JPWO2008059927A1 (ja) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101568552B (zh) | 胶原肽组合物以及含有其的饮食品 | |
CN102428094B (zh) | 血中转运性高的胶原肽组合物及含有其的饮食品 | |
JP6414821B2 (ja) | ペプチドを原料とする機能性と嗜好性に優れた素材およびこれを用いた食品・ペットフード | |
JP5276813B2 (ja) | エラスチン分解ペプチド並びにエラスチン及びその酵素分解ペプチドの製造方法 | |
JP5736533B2 (ja) | 抗ストレス作用と嗜好性向上効果を備えたペプチド性ペットフード素材 | |
JP5745402B2 (ja) | α−ラクトアルブミン由来のトリプトファン含有ペプチドを含有する乳漿タンパク質加水分解物およびその使用 | |
JP2019516412A (ja) | 低分子コラーゲンペプチドおよびこれを用いた食品組成物の製造方法 | |
US9828439B2 (en) | Hybrid vegetable protein and method for obtaining same | |
JP5326489B2 (ja) | コラーゲンを原料とする保健的機能性と嗜好性向上効果を備えた食品・ペットフード素材 | |
JP2003511093A (ja) | 海洋プロテアーゼを用いて製造されるタンパク質加水分解物 | |
RU2388350C1 (ru) | Белково-пептидный модуль для производства продуктов функционального и специализированного питания для лиц, подверженных интенсивным физическим нагрузкам | |
JP6143218B2 (ja) | 腱および靱帯機能改善剤ならびにこれを含む医薬組成物、食品および飼料 | |
JPH0453471A (ja) | 骨強化食品、飼料及び医薬 | |
KR101441728B1 (ko) | 골흡수 억제용 식품 소재 | |
Igual et al. | Amino acids and protein in vitro bio-accessibility from edible insect and pea protein enriched bread | |
KR20230098939A (ko) | 누에고치 효소 가수분해물을 포함하는 항염증용 조성물 | |
KR20210076222A (ko) | 누에고치 가수분해물을 포함하는 칼슘 흡수 촉진용 조성물 | |
MXPA96004493A (en) | Completely dissolved materials of hardwork and method to produce myself |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1136586 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: MEIJI KK Free format text: FORMER OWNER: MEIJI SEIKA KAISHA, LTD. (JP) TOKYO, JAPAN Effective date: 20111207 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20111207 Address after: Tokyo, Japan, Japan Applicant after: Meiji Co., Ltd. Address before: Tokyo, Japan, Japan Applicant before: Meiji Seika Kaisha, Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1136586 Country of ref document: HK |